A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy
Francis J. Giles*, Roberto Rodriguez, Daniel Weisdorf, John R. Wingard, Paul J. Martin, Thomas R. Fleming, Stuart L. Goldberg, Elias J. Anaissie, Brian J. Bolwell, Nelson J. Chao, Thomas C. Shea, Mark M. Brunvand, William Vaughan, Finn Petersen, Mark Schubert, Hillard M. Lazarus, Richard T. Maziarz, Margarida Silverman, Roy A. Beveridge, Rebecca RedmanJanis G. Pulliam, Patricia Devitt-Risse, Henry J. Fuchs, David D. Hurd
Dive into the research topics of 'A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy'. Together they form a unique fingerprint.